Some basic chart analysis on Genmab.
This is more to bring your attention to the stocks long term growth prospects.
With a TTM P/E ratio
of 29 and a FWD
of 3, combined with solid revenue growth TTM
leads me to suggest that Genmab will thrive in the coming months and climb to all time highs.